These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2943537)

  • 1. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
    Czernielewski JM; Schmitt D; Faure MR; Thivolet J
    Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants.
    Foster CA; Holbrook KA; Farr AG
    J Invest Dermatol; 1986 Mar; 86(3):240-3. PubMed ID: 2427603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-DR and OKT6 antigens on keratinocytes and dendritic cells in pemphigus.
    Picut C; Meunier J; Lee C; Lewis R
    Arch Dermatol Res; 1987; 279(8):516-20. PubMed ID: 2449139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
    Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
    Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man.
    Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J
    Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes.
    Basham TY; Nickoloff BJ; Merigan TC; Morhenn VB
    J Invest Dermatol; 1984 Aug; 83(2):88-90. PubMed ID: 6206165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
    Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
    Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATPase, antigens detected by monoclonal antibodies, ultrastructural characters: which is the best marker for Langerhans cells?
    De Panfilis G
    Arch Dermatol Res; 1983; 275(6):407-11. PubMed ID: 6229220
    [No Abstract]   [Full Text] [Related]  

  • 13. Normal and neoplastic Langerhans cells: phenotypic comparison with other types of macrophages.
    Ralfkiaer E; Stein H; Ralfkiaer N; Hou-Jensen K; Mason DY
    Adv Exp Med Biol; 1985; 186():1009-15. PubMed ID: 3876694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity pattern of anti-CD1 and anti-HLA class II monoclonal antibodies with human eccrine sweat glands.
    Gomes M; Staquet MJ; Dezutter-Dambuyant C; Kanitakis J; Schmitt D; Capra JD; Thivolet J
    Tissue Antigens; 1986 Mar; 27(3):163-71. PubMed ID: 2424140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of Langerhans cells with hybridoma antibody.
    Fithian E; Kung P; Goldstein G; Rubenfeld M; Fenoglio C; Edelson R
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2541-4. PubMed ID: 6941307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Langerhans cells: methods of identification].
    Nicolas C; Schmitt D
    Pathol Biol (Paris); 1984 Mar; 32(3):199-208. PubMed ID: 6232489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR antigen expression on the keratinocyte surface in dermatoses characterized by lymphocytic exocytosis (e.g. pityriasis rosea).
    Aiba S; Tagami H
    Br J Dermatol; 1984 Sep; 111(3):285-94. PubMed ID: 6206885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Langerhans cells and keratinocytes in epidermal immunity.
    Choi KL; Sauder DN
    J Leukoc Biol; 1986 Mar; 39(3):343-58. PubMed ID: 2418143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.
    Westerhof W; Groot I; Krieg SR; Bos JD; Cormane RH
    Acta Derm Venereol; 1986; 66(3):259-62. PubMed ID: 2426905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.